A STUDY TO ASSESS THE EFFECTIVENESS OF IMMUNRICH IN COVID 19 POSITIVE PATIENTS

A CLINICAL STUDY TO ASSESS THE EFFICACY OF CAP IMMURICH IN COVID19 POSITIVE PATIENTS - COVID19 IMMURICH

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/12/029713

Enrollment

100

Registered

2020-12-10

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J988- Other specified respiratory disorders

Interventions

Intervention1: CAP IMMURICH : 2 BID BEFORE MEAL WITH LUKEWARM WATER DURATION 28 DAYS Control Intervention1: NOT APPICABLE: NOT APPICABLE

Eligibility

Inclusion criteria

Inclusion criteria: 2. RT-PCR Based Corona positive patient and rapid antigen test 3. Consent to participate in the trial

Exclusion criteria

Exclusion criteria: 1. Individual with uncontrolled unstable comorbidities 2. Individual with pre- existing respiratory conditions 3. Immunocompromised individuals or those on immunosuppressants 4. Patients on or requiring parenteral nutrition 5. Pregnant and lactating female

Design outcomes

Primary

Measure	Time frame
1. Improvement in Bala of an individual 2. Immuno- stimulation leading to non-development of Covid-19 in risk population exposed to infected individual Timepoint: assessment after 1 week 1. Improvement in Bala of an individual 2. Immuno- stimulation leading to non-development of Covid-19 in risk population exposed to infected individual	—

Secondary

Measure	Time frame
IMPROVEMENT IN QUALITY OF LIFETimepoint: Assessment after 4 weeks IMPROVEMENT OF QUALITY OF LIFE	—

Countries

India

Contacts

Public ContactDR MANOJ RUNGHE

K J INSTITUTE OF AYURVED AND RESEARCH AFFILATED TO KASHIBA AYURVED HOSPITAL SAVLI SAVLI VADODARA

principal.kjiar@kjit.org9687748944

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026